Although many molecular markers, including carcinoembryonic antigen (CEA), have been exploited for CRC diagnosis, they lack sensitivity and specificity of evaluating the prognosis of CRC patient [31]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.